Erasmus MC Biomedical Fund finances early-stage companies in the biotechnology and biomedical field and is an independent investment firm.
Business Model:
Revenue: $10M
Employees: 2-10
Address:
City:
State:
Zip:
Country:
Erasmus MC Biomedical Fund finances early-stage companies in the biotechnology and biomedical field and is an independent investment firm. The Erasmus MC Biomedical Fund is a specialist fund, targeting companies that are developing commercially promising products and technologies in life sciences, including: pharmaceuticals, biotechnology, medical devices and other high technology opportunities that offer venture capital returns.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
9/2009 | arGEN-X | Series A | 13.6M |
5/2009 | Cavadis | Series A | - |
2/2010 | arGEN-X | Series A | 4.5M |
12/2011 | arGEN-X | Series B | 43.8M |
12/2007 | RiverD International | Venture Round | - |
4/2008 | Therosteon | Venture Round | - |
12/2011 | arGEN-X | Series B | 0 |
2/2010 | arGEN-X | Series A | 0 |
9/2009 | arGEN-X | Series A | 0 |
5/2009 | Cavadis | Series A | - |
4/2008 | Therosteon | Venture Round | - |
12/2007 | RiverD International | Venture Round | - |
Name | Price |
---|
Name | Size | Announced Date |
---|